Parkinson'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Eligibility criteria included a clinical diagnosis of PD with a disease severity rating of stage 3 to 4 on the Hoehn and Yahr scale,stable medication use, medical clearance for participation, and willingness to participate in treatment and outcome testing.
Exclusion criteria
Exclusion criteria: Exclusion criteria were current participation in any other behavioral or pharmacologic study or debilitating conditions that would impede full participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UPDRS parts 1-4 | — |
Secondary
| Measure | Time frame |
|---|---|
| MMSE, FAB, SDS | — |
Countries
Japan
Contacts
Tokushima National Hospital, National Hospital Organization Department of Clinical Research